Search Within

George Raptis

Formats
  1. Journal Article (13)
  2. Meeting Abstract (12)
  3. Conference Paper (3)
  4. Book Section (1)
Groups
  1. Department of Medicine (29)
  2. Breast Medicine Service (27)
  3. Solid Tumor Oncology Division (27)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (26)
  5. Survivorship Research (19)
  6. Behavioral Sciences Service (13)

More Groups

People
  1. Larry Norton (26)
  2. David Fennelly (20)
  3. Clifford Hudis (17)
  4. Andrew Seidman (15)
  5. John Crown (14)
  6. Jose Baselga (13)

More People

Years
  1. 1999 (3)
  2. 1998 (2)
  3. 1997 (2)
  4. 1996 (4)
  5. 1995 (8)
  6. 1994 (6)

More Years

Publications
  1. Blood (7)
  2. Breast Cancer Research and Treatment (4)
  3. Seminars in Oncology (4)
  4. Journal of Clinical Oncology (3)
  5. Cancer Investigation (2)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Elsevier Inc. (6)
  3. Springer (4)
  4. American Association for Cancer Research (3)
  5. American Society of Clinical Oncology (3)
  6. Informa Healthcare (2)

More Publishers

Results (29)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pilot study of 5-azacytidine (5-AZA) and carboplatin (CBDCA) in patients with relapsed/refractory leukemia
    Journal Article

    Kritz, A. D.; Raptis, G.; Menendez-Botet, C.; Maslak, P.; Jakubowski, A.
    American Journal of Hematology (1996)

    Fulltext@MSK | Save
  • Phase I trial of sequential edatrexate (etx) followed by paclitaxel (ptx): A design based on in vitro (IV) synergy in patients with advanced breast cancer
    Meeting Abstract

    Fennelly, D.; Gilewski, T.; Hudis, C.; Seidman, A.; Raptis, G.; Baselga, J.; Sklarin, N.; Norton, L.
    Proceedings of the American Association for Cancer Research Annual Meeting (1995)

    Fulltext@MSK | Save
  • High-dose chemotherapy of breast cancer: Current status and developmental strategies
    Meeting Abstract

    Crown, J.; Raptis, G.; Hamilton, N.; Fennelly, D.; Vahdat, L.; Norton, L.
    European Journal of Cancer (1995)

    Fulltext@MSK | Save
  • Rapid hematologic recovery following CD34+ selected versus unselected peripheral blood progenitor cell (PBPC) plus filgrastim (G) rescue of sequential high dose chemotherapy (HDC) in patients (PTS) with metastatic breast cancer (MBC)
    Meeting Abstract

    Raptis, G.; Tiersten, A.; Shapiro, F.; Schneider, J.; Hamilton, N.; Reich, L.; Wuest, D.; Gucciardo, A.; Quiguyan, L.; Gilewski, T.; more...
    Blood (1995)

    Fulltext@MSK | Save
  • Carboplatin and etoposide in metastatic breast cancer
    Journal Article

    Crown, J.; Hamilton, N.; Raptis, G.; Kritz, A.; Vahdat, L.; Norton, L.
    Annals of Oncology (1995)

    Fulltext@MSK | Save
  • Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer
    Conference Paper

    Seidman, A. D.; Hudis, C. A.; Fennelly, D.; Raptis, G.; Baselga, J.; Norton, L.
    Elsevier Inc. (1995)

    Fulltext@MSK | Save
  • High-dose chemotherapy of metastatic breast cancer: A review
    Journal Article

    Vahdat, L.; Raptis, G.; Fennelly, D.; Crown, J.
    Cancer Investigation (1995)

    Fulltext@MSK | Save
  • Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes
    Journal Article

    Hudis, C. A.; Seidman, A. D.; Baselga, J.; Raptis, G.; Lebwohl, D.; Gilewski, T.; Currie, V.; Moynahan, M. E.; Sklarin, N.; Fennelly, D.; more...
    Seminars in Oncology (1995)

    Fulltext@MSK | Save
  • Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer
    Journal Article

    Vahdat, L.; Raptis, G.; Fennelly, D.; Hamilton, N.; Reich, L.; Tiersten, A.; Harrison, M.; Hudis, C.; Moore, M.; Yao, T. J.; more...
    Clinical Cancer Research (1995)

    Fulltext@MSK | Save
  • Phase I trial of sequential edatrexate (ETX) followed by paclitaxel (PTX) in patients with advanced breast cancer: A design based on in-vitro (IV) synergy
    Meeting Abstract

    Fennelly, D.; Hudis, C.; Seidman, A.; Hamilton, N.; Raptis, G.; Baselga, J.; Sklarin, N.; Norton, L.
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save